Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Engrail Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Engrail Therapeutics

Engrail Therapeutics

Developing and commercializing transformative medicines for life-limiting nervous system diseases.

HQ
San Diego, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Engrail Therapeutics is a clinical-stage pharmaceutical company focused on developing and commercializing transformative medicines for life-limiting nervous system diseases. The company leverages its scientific expertise in molecular mechanisms and neurocircuitry to address the needs of patients with devastating neurological disorders. Engrail's core mission is to transform the lives of these patients through precision neuroscience, offering innovative therapies that target complex conditions.

Notable affiliated individuals and investors include experienced professionals in the pharmaceutical and biotech industries, though specific names are not provided. Key achievements include advancing their pipeline of treatments to clinical stages, demonstrating their commitment to impactful medical innovation. Engrail Therapeutics aims to make a significant impact on the healthcare market by providing effective solutions for previously unmet medical needs in neurology.

Engrail Therapeutics - Similar Companies

Pipeline Therapeutics logo

Pipeline Therapeutics

Escape Bio logo

Escape Bio

escapebio.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Chase Therapeutics logo

Chase Therapeutics

Novoron Bioscience logo

Novoron Bioscience

novoron.com

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Enterin logo

Enterin

enterininc.com

Spinogenix logo

Spinogenix

spinogenix.com

Cerebral Therapeutics logo

Cerebral Therapeutics

Neuron23 logo

Neuron23

Neurovia logo

Neurovia

Nido Biosciences logo

Nido Biosciences

nidobio.com

NeuroGenetic Pharmaceuticals logo

NeuroGenetic Pharmaceuticals

Cygnal Therapeutics logo

Cygnal Therapeutics

Axonis Therapeutics logo

Axonis Therapeutics

Engrail Therapeutics - Quick Facts

Who are Engrail Therapeutics' competitors?

Companies similar to Engrail Therapeutics include Pipeline Therapeutics, Escape Bio, NeuroTherapeutics Pharma and Chase Therapeutics.

When was Engrail Therapeutics founded?

Engrail Therapeutics was founded in 2019.

Where is Engrail Therapeutics' headquarters located?

Engrail Therapeutics' headquarters is located in San Diego, CA, US.

When was Engrail Therapeutics' last funding round?

Engrail Therapeutics' most recent funding round was for $32M (USD) in August 2021.

How much has Engrail Therapeutics raised to-date?

As of Aug 3, 2021, Engrail Therapeutics has raised a total of $64M (USD).

How many employees does Engrail Therapeutics have?

Engrail Therapeutics has 23 employees as of Feb 4, 2024.

Engrail Therapeutics - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research